User contributions
Jump to navigation
Jump to search
- 05:26, 25 November 2015 diff hist +2,254 Non-small cell lung cancer added regimen
- 04:47, 25 November 2015 diff hist 0 File:Panitumumab.pdf PeterYang uploaded a new version of File:Panitumumab.pdf current
- 04:43, 25 November 2015 diff hist +2,188 Necitumumab (Portrazza) FDA approval
- 04:21, 25 November 2015 diff hist +177 N File:Necitumumab.pdf Necitumumab (Portrazza) package insert (locally hosted backup). Original source: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125547s000lbl.pdf, accessed 11/24/2015. current
- 04:18, 25 November 2015 diff hist +37 N Necitumumab (IMC-11F8) PeterYang moved page Necitumumab (IMC-11F8) to Necitumumab (Portrazza) current
- 04:18, 25 November 2015 diff hist 0 m Necitumumab (Portrazza) PeterYang moved page Necitumumab (IMC-11F8) to Necitumumab (Portrazza)
- 12:28, 24 November 2015 diff hist 0 File:Nivolumab.pdf PeterYang uploaded a new version of File:Nivolumab.pdf
- 12:27, 24 November 2015 diff hist +80 Nivolumab (Opdivo)
- 12:22, 24 November 2015 diff hist +1,586 NovoTTF-100A system (Optune)
- 12:09, 24 November 2015 diff hist +272 N File:Novottf.pdf NovoTTF-100A FDA neurological device information (locally hosted backup). Original source: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/NeurologicalDevicesPanel/UCM247168.pdf,... current
- 12:06, 24 November 2015 diff hist +207 N File:Novottf SSED.pdf NovoTTF-100A system (Optune) FDA summary of safety and effectiveness data (SSED) (locally hosted backup). Original source: http://www.accessdata.fda.gov/cdrh_docs/pdf10/P100034S013b.pdf, accessed 11/24/2015. current
- 12:02, 24 November 2015 diff hist 0 m Drug index
- 12:02, 24 November 2015 diff hist +42 N NovoTTF-100A device (Optune) PeterYang moved page NovoTTF-100A device (Optune) to NovoTTF-100A system (Optune) current
- 12:02, 24 November 2015 diff hist 0 m NovoTTF-100A system (Optune) PeterYang moved page NovoTTF-100A device (Optune) to NovoTTF-100A system (Optune)
- 11:48, 24 November 2015 diff hist +9 m Drug index →N
- 11:47, 24 November 2015 diff hist +42 N NovoTTF-100A device PeterYang moved page NovoTTF-100A device to NovoTTF-100A device (Optune)
- 11:47, 24 November 2015 diff hist 0 m NovoTTF-100A system (Optune) PeterYang moved page NovoTTF-100A device to NovoTTF-100A device (Optune)
- 15:43, 21 November 2015 diff hist +3,170 Multiple myeloma added regimen
- 15:26, 21 November 2015 diff hist +262 m Ixazomib (Ninlaro)
- 15:17, 21 November 2015 diff hist +260 m Ixazomib (Ninlaro)
- 14:54, 21 November 2015 diff hist +959 Ixazomib (Ninlaro) FDA approval
- 14:23, 21 November 2015 diff hist +161 N File:Ixazomib.pdf Ixazomib (Ninlaro) package insert (locally hosted backup). Original source: http://www.ninlarohcp.com/downloads/Prescribing-Information.pdf, accessed 11/21/2015. current
- 23:03, 16 November 2015 diff hist -902 m Daratumumab (Darzalex)
- 23:01, 16 November 2015 diff hist +4,392 Multiple myeloma added regimen
- 20:33, 16 November 2015 diff hist +34 m Style guide
- 20:32, 16 November 2015 diff hist +1,722 Daratumumab (Darzalex) FDA approval
- 19:54, 16 November 2015 diff hist +169 N File:Daratumumab.pdf Daratumumab (Darzalex) package insert (locally hosted backup). Original source: www.accessdata.fda.gov/drugsatfda_docs/label/2015/761036s000lbl.pdf, accessed 11/16/2015.
- 19:53, 16 November 2015 diff hist +3 m Drug index
- 19:52, 16 November 2015 diff hist +36 N Daratumumab (HuMax-CD38) PeterYang moved page Daratumumab (HuMax-CD38) to Daratumumab (Darzalex): FDA approval current
- 19:52, 16 November 2015 diff hist 0 m Daratumumab (Darzalex) PeterYang moved page Daratumumab (HuMax-CD38) to Daratumumab (Darzalex): FDA approval
- 08:16, 14 November 2015 diff hist +2,988 Non-small cell lung cancer added regimen
- 07:19, 14 November 2015 diff hist +672 Osimertinib (Tagrisso) FDA approval
- 07:16, 14 November 2015 diff hist +25 m Cobimetinib (Cotellic)
- 06:43, 14 November 2015 diff hist +150 N File:Osimertinib.pdf Osimertinib (Tagrisso) package insert (locally hosted backup). Original source: http://www.azpicentral.com/tagrisso/tagrisso.pdf, accessed 11/14/2015.
- 02:15, 13 November 2015 diff hist +1,968 N Rasburicase (Elitek) Created page with "==General information== Class/mechanism: Recombinant urate-oxidase. Rasburicase catalyzes the enzymatic oxidation of poorly soluble uric acid into allantoin, an inactive and m..."
- 01:45, 13 November 2015 diff hist 0 File:Rasburicase.pdf PeterYang uploaded a new version of File:Rasburicase.pdf current
- 01:40, 13 November 2015 diff hist -42 m Drug index →G
- 01:39, 13 November 2015 diff hist +54 m Drug index
- 08:04, 11 November 2015 diff hist 0 File:Vemurafenib.pdf PeterYang uploaded a new version of File:Vemurafenib.pdf current
- 07:46, 11 November 2015 diff hist +2,185 Melanoma added regimen
- 07:33, 11 November 2015 diff hist +2,258 N Cobimetinib (Cotellic) FDA approval
- 07:32, 11 November 2015 diff hist -2 m Talimogene laherparepvec (Imlygic) →General information
- 07:04, 11 November 2015 diff hist +134 Dabrafenib (Tafinlar)
- 07:03, 11 November 2015 diff hist +343 Trametinib (Mekinist)
- 06:58, 11 November 2015 diff hist 0 File:Dabrafenib.pdf PeterYang uploaded a new version of File:Dabrafenib.pdf
- 06:56, 11 November 2015 diff hist 0 File:Trametinib.pdf PeterYang uploaded a new version of File:Trametinib.pdf current
- 06:55, 11 November 2015 diff hist -122 Trametinib (Mekinist)
- 06:42, 11 November 2015 diff hist +176 N File:Cobimetinib.pdf Cobimetinib (Cotellic) package insert (locally hosted backup). Original source: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206192s000lbl.pdf, accessed 11/11/2015. current
- 09:21, 4 November 2015 diff hist +2,205 N Galeterone (TOK-001) Created page with "'''In clinical trials.''' ==General information== Class/mechanism: Antiandrogen with multiple mechanisms of action: androgen receptor inhibitor (ARI), androgen biosynthesis i..."
- 18:34, 31 October 2015 diff hist +1,193 Atezolizumab (Tecentriq)